FDA Expands Guidance on Patient Preference Information to Include Total Product Lifecycle

The FDA offers updated advice to medical device sponsors on how to use patient preference information (PPI) throughout the product lifecycle, in a new draft guidance. Source: Drug Industry Daily

Continue ReadingFDA Expands Guidance on Patient Preference Information to Include Total Product Lifecycle

Berkeley Biologics Draws Warning Letter for Unapproved Bone Matrix Products

Richmond, Calif.-based Berkeley Biologics failed to file BLAs for several bone matrix products distributed to medical facilities nationwide and lacked proper screening for tissue donors, among other serious lapses cited…

Continue ReadingBerkeley Biologics Draws Warning Letter for Unapproved Bone Matrix Products